bluebird bio, Inc. BLUE
At closeJun 2, 2025, 4:00 PM EDT
52-week range unavailable
- YTD
- -40.41%
- 1 year
- -72.25%
Discussion (235)
Sign in to join the discussion
It’s as obvious as the nose on your face it is blatantly being manipulated. Duh
You know as I do the valuation is ridiculous and at 193 market cap absurd by any measure
This stock could easily drop to .50 until the momentum changes. You can forget the market cap because until you have a genuine turn around in biotech or more buyers than sellers it’s a red headed stepchild
It will take at least a year to hit $3
By waiting to long management will destroy the value of the company in a buyout. The management should be aggressively searching for a buyer
This stock done hedgfund got their money back
It’s not a retail game anymore it’s indexed and ETF that call the shots. I think an acquisition is the only hope but it has to happen very soon or we did on the vine. The rules have changed forever and the biotech glory runs are kaput.
The horrible management of this company sealed its fate, they were research driven but not good financial leadership
Institutional investors are just tossing dice on this and don’t care win or lose, it’s like buying a 100-1 horse with pocket money. These guys spend twice that amount on their Xmas parties. You can’t take it seriously
I have a reality check, you explain to me how the true value of BLUE is 175 mill cap? I get that Wall Street could drive it down to 0 but I’m talking about the enterprise valuation. What am I missing here? The court case will be settled for a few $ because the plaintiff can’t possibly do anything with a victory
